PTCT PTC Therapeutics
- 33.010
- -0.610-1.81%
PTC Therapeutics News
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Klein Matthew B.
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pauwels Eric
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Klein Matthew B.
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Golden Lee Scott
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Almstead Neil Gregory
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Utter Christine Marie
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pauwels Eric
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SCHMERTZLER MICHAEL
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Okey Stephanie
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SOUTHWELL DAVID P
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bell William F. Jr.
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Smith Mary L.
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director STEELE GLENN JR MD PHD
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Young Alethia
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ZELDIS JEROME B
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Jacobson Allan Steven
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Reeve Emma
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Boulding Mark Elliott
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Klein Matthew B.
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Golden Lee Scott
Analysis
Price Target
No Data
